AR023528A1 - Derivados de ciclobuten-3,4-diona, su preparacion y su aplicacion en terapeutica - Google Patents

Derivados de ciclobuten-3,4-diona, su preparacion y su aplicacion en terapeutica

Info

Publication number
AR023528A1
AR023528A1 ARP000101798A ARP000101798A AR023528A1 AR 023528 A1 AR023528 A1 AR 023528A1 AR P000101798 A ARP000101798 A AR P000101798A AR P000101798 A ARP000101798 A AR P000101798A AR 023528 A1 AR023528 A1 AR 023528A1
Authority
AR
Argentina
Prior art keywords
group
application
hydrogen atom
ciclobuten
diona
Prior art date
Application number
ARP000101798A
Other languages
English (en)
Original Assignee
Addario Ezio Nicola D
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Addario Ezio Nicola D filed Critical Addario Ezio Nicola D
Publication of AR023528A1 publication Critical patent/AR023528A1/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/08—Drugs for disorders of the urinary system of the prostate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C237/00—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups
    • C07C237/24—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups having the carbon atom of at least one of the carboxamide groups bound to a carbon atom of a ring other than a six-membered aromatic ring of the carbon skeleton
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/04—Indoles; Hydrogenated indoles
    • C07D209/08—Indoles; Hydrogenated indoles with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, directly attached to carbon atoms of the hetero ring
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2601/00—Systems containing only non-condensed rings
    • C07C2601/04—Systems containing only non-condensed rings with a four-membered ring
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2601/00—Systems containing only non-condensed rings
    • C07C2601/12—Systems containing only non-condensed rings with a six-membered ring
    • C07C2601/14—The ring being saturated

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Diabetes (AREA)
  • Urology & Nephrology (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Endocrinology (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Emergency Medicine (AREA)
  • Vascular Medicine (AREA)
  • Epidemiology (AREA)
  • Reproductive Health (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Indole Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)

Abstract

Los compuestos responden a la formula general (1): en la cual: R1 y R2 representan, independientemente entre sí, un átomo de hidrogeno o un grupo C1-6alquilo, un grupo C2-6 alquenilo, un grupo -(CH2)n-C3-6 cicloalquilo; R3 representa un átomo de hidrogeno o un grupo C1-6, alquilo, W representa un grupoNR4R5, en el cual R4 representa un grupo fenilo cuando R5 representa un átomo de hidrogeno, un grupo C1-6 alquilo o un grupo C2-6 alquenilo, o R4 y R5 formanjunto con el nitrogeno que los lleva unheterociclo nitrogenado elegido entre un indol, una indolina o una quinoleina, y n representa 0, 1 o 2. Aplicacion enterapéutica
ARP000101798A 1999-04-20 2000-04-18 Derivados de ciclobuten-3,4-diona, su preparacion y su aplicacion en terapeutica AR023528A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR9904944A FR2792635B1 (fr) 1999-04-20 1999-04-20 Derives de cyclobutene-3,4-dione leur preparation et leur application en therapeutique

Publications (1)

Publication Number Publication Date
AR023528A1 true AR023528A1 (es) 2002-09-04

Family

ID=9544619

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP000101798A AR023528A1 (es) 1999-04-20 2000-04-18 Derivados de ciclobuten-3,4-diona, su preparacion y su aplicacion en terapeutica

Country Status (6)

Country Link
AR (1) AR023528A1 (es)
AU (1) AU3971700A (es)
CO (1) CO5170443A1 (es)
FR (1) FR2792635B1 (es)
UY (1) UY26111A1 (es)
WO (1) WO2000063170A1 (es)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6403597B1 (en) 1997-10-28 2002-06-11 Vivus, Inc. Administration of phosphodiesterase inhibitors for the treatment of premature ejaculation
US6548490B1 (en) 1997-10-28 2003-04-15 Vivus, Inc. Transmucosal administration of phosphodiesterase inhibitors for the treatment of erectile dysfunction
DE10058663A1 (de) * 2000-11-25 2002-05-29 Merck Patent Gmbh Verwendung von Thienopyrimidinen
US20040106794A1 (en) * 2001-04-16 2004-06-03 Schering Corporation 3,4-Di-substituted cyclobutene-1,2-diones as CXC-chemokine receptor ligands
AR068509A1 (es) * 2007-09-19 2009-11-18 Jerini Ag Antagosnistas del receptor de bradiquinina b1

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9312210D0 (en) * 1993-06-14 1993-07-28 Smithkline Beecham Plc Chemical compounds
ATE303365T1 (de) * 1995-12-28 2005-09-15 Fujisawa Pharmaceutical Co Benzimidazolderivate

Also Published As

Publication number Publication date
FR2792635B1 (fr) 2001-06-01
CO5170443A1 (es) 2002-06-27
FR2792635A1 (fr) 2000-10-27
WO2000063170A1 (fr) 2000-10-26
UY26111A1 (es) 2000-12-29
AU3971700A (en) 2000-11-02

Similar Documents

Publication Publication Date Title
CO5590895A2 (es) Derivados de sulfonamidas, su preparacion y su aplicacion como medicamentos
DK1131315T3 (da) Polyhydroxylerede heterocykliske derivater som antikoagulanter
LU92993I2 (fr) Briviact
AR029216A1 (es) Compuestos inhibidores no peptidicos de la union celular dependiente de vla-4 utiles en el tratamiento de enfermedades inflamatorias, autoinmunes y respiratorias; composicion farmaceutica y procedimiento de tratamiento
CO5611139A2 (es) Pirimidinas aril sustituidas y el uso de las mismas
ES2184280T3 (es) Compuestos de indol como inhibidores de cox-2'.
DE69814375D1 (de) Fungizide trifluoromethylalkylamino-triazolopyrimidine-derivate
TR200100439T2 (tr) 1H-İmidazopiridin türevleri
CL2004001072A1 (es) Compuestos derivados de trifluorofenil-triazolopirimidina; procedimiento de preparacion de los compuestos; compuestos intermediarios utiles como fungicidas.
ECSP045104A (es) Ligandos de los receptores de los cannabinoides
ES2124167B1 (es) Nuevos derivados del bencimidazol con actividad antihistaminica.
ATE389635T1 (de) Pharmazeutisch wirksame piperidinderivate
ES2091615T3 (es) Derivados de indol fungicidas.
CO5050296A1 (es) Derivados de 1-arenosulfonil-2-arilo-pirrolidina y de piperidina
DK1643984T3 (da) Anvendelse af parthenolidderivater som antileukæmiske og cytotoksske midler
ATE249457T1 (de) Indolderivate und ihre verwendung als serotoninrezeptor-liganden
RS50229B (sr) Analozi vitamina d3
CR7249A (es) Derivados de diamina, proceso para producir los derivados de diamina, y funguicidas que contienen los derivados de diamina como ingrediente activo
AR023528A1 (es) Derivados de ciclobuten-3,4-diona, su preparacion y su aplicacion en terapeutica
ATE239722T1 (de) Benzofurylpiperazine als serotonin-agonisten
AR012730A1 (es) Compuestos derivados de aminocicloalquilpirrolidina sustituida cis-sustituidos, droga, agente antimicrobiano y compuesto intermediario
AR008168A1 (es) Compuestos etilamino arilamida aril substituidos de pirrolidinilo y pirrolinilo, composicion farmaceutica que lo contiene, compuesto util para susintesis, procedimiento para su preparacion
AR040571A1 (es) Derivados de aciloxipirrolidina, su preparacion y su aplicacion en terapeutica
DE69423055T2 (de) Indol Derivate als Glutamat Antagonisten
ES2169909T3 (es) 5-hidroximetil-2-aminotetralinas como agentes cardiovasculares.